NextCure Inc reports results for the quarter ended June 30 - Earnings Summary
NextCure Inc expected to post a loss of $4.61 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Nvidia, Strategy, Targa Resources
NextCure signs up to $745 million deal with China's Simcere to develop cancer drug
Brief: Simcere Pharmaceutical's Unit Enters Into License Agreement With Nextcure
Brief: Nextcure And Simcere Zaiming Announce Strategic Partnership For A Novel Antibody-Drug Conjugate Targeting CDH6
NextCure Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: NextCure Q1 Net Income USD -10.976 Million
NextCure Inc expected to post a loss of 40 cents a share - Earnings Preview
NextCure Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: NextCure Q3 Net Income USD -11.54 Million
NextCure Inc expected to post a loss of 34 cents a share - Earnings Preview
NextCure Inc reports results for the quarter ended in January - Earnings Summary
Brief: NextCure Q2 Net Income USD -15.404 Million
Brief: NextCure Q1 Net Income USD -17.107 Million
NextCure Inc expected to post a loss of 46 cents a share - Earnings Preview
Brief: NextCure Appoints Rakesh Dixit To Scientific Advisory Board
Brief: NextCure FY Net Income USD -62.723 Million
Brief: NextCure Publishes Preclinical Data Demonstrating Function Of FLRT3 As T Cell Inhibitor In Science Advances